StockDriftsStockDriftsTop 3 Kpcb Xiii Associates, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PGNY | Progyny, Inc. | 92.97% | 5.07M | $172.6M | +0.00%(+0) | — | 2023-09-30 | |
| LUNG | Pulmonx Corporation | 5.53% | 995.0K | $10.3M | +0.00%(+0) | — | 2023-09-30 | |
| MVLA | Movella Holdings Inc. | 1.5% | 5.19M | $2.8M | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Kpcb Xiii Associates, Llc reports $185.70M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are PGNY (93.0%), LUNG (5.5%) and MVLA (1.5%). Figures reflect the Q3 2023 filing.
Sign up free to track Kpcb Xiii Associates, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Kpcb Xiii Associates, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1500595). View Kpcb Xiii Associates, Llc’s 13F filings on SEC